92.54
+0.49
+(0.53%)
At close: April 17 at 4:00:02 PM EDT
92.54
0.00
(0.00%)
After hours: April 17 at 6:52:54 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 26 | 25 |
| Avg. Estimate | 0.76 | 0.78 | 3.23 | 3.76 |
| Low Estimate | 0.73 | 0.75 | 3.16 | 3.5 |
| High Estimate | 0.82 | 0.82 | 3.61 | 4.29 |
| Year Ago EPS | 0.78 | 0.74 | 3.05 | 3.23 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 20 | 19 |
| Avg. Estimate | 2.52B | 2.61B | 10.42B | 11.17B |
| Low Estimate | 2.5B | 2.56B | 10.19B | 10.8B |
| High Estimate | 2.54B | 2.68B | 10.85B | 11.82B |
| Year Ago Sales | 2.46B | 2.5B | 9.91B | 10.42B |
| Sales Growth (year/est) | 2.67% | 4.63% | 5.09% | 7.20% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.73 | 0.73 | 0.74 | 0.72 |
| EPS Actual | 0.78 | 0.74 | 0.81 | 0.72 |
| Difference | 0.05 | 0.01 | 0.07 | 0 |
| Surprise % | 7.01% | 1.45% | 8.79% | 0.57% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.76 | 0.78 | 3.23 | 3.76 |
| 7 Days Ago | 0.76 | 0.78 | 3.24 | 3.77 |
| 30 Days Ago | 0.77 | 0.78 | 3.26 | 3.77 |
| 60 Days Ago | 0.82 | 0.81 | 3.34 | 3.84 |
| 90 Days Ago | 0.83 | 0.82 | 3.36 | 3.86 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | -- | -- | 4 | 5 |
| Down Last 7 Days | 2 | 1 | 3 | 3 |
| Down Last 30 Days | 1 | 1 | 10 | 7 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALC | -1.97% | 5.34% | 6.04% | 16.39% |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
| Maintains | Keybanc: Overweight to Overweight | 3/31/2025 |
| Maintains | Mizuho: Outperform to Outperform | 3/28/2025 |
| Maintains | Needham: Buy to Buy | 3/28/2025 |
| Reiterates | Needham: Buy to Buy | 3/20/2025 |
| Maintains | Baird: Outperform to Outperform | 2/27/2025 |
| Maintains | Needham: Buy to Buy | 2/27/2025 |
Related Tickers
BLCO Bausch + Lomb Corporation
12.06
+1.77%
COO The Cooper Companies, Inc.
79.51
+1.64%
UTMD Utah Medical Products, Inc.
52.30
-0.19%
ANGO AngioDynamics, Inc.
9.52
+0.63%
RMD ResMed Inc.
212.91
+0.67%
BAX Baxter International Inc.
28.89
+3.85%
AVTR Avantor, Inc.
15.10
-0.98%
BDX Becton, Dickinson and Company
198.71
-0.84%
WST West Pharmaceutical Services, Inc.
201.90
-3.46%
PDEX Pro-Dex, Inc.
60.83
-0.82%